Skip to search formSkip to main contentSkip to account menu

BM 13505

Known as: BM 13.505, BM-13505 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The effects of platelet-activating factor (PAF) on vascular resistance and capillary permeability were studied in the isolated… 
1994
1994
1 The objectives of the present experiments were to assess the role of ETA receptors in mediating endothelin‐1 (ET‐1)‐induced… 
1993
1993
The antithrombotic effects of the thromboxane (TX) A2-receptor antagonist and aspirin were determined using a photochemically… 
1993
1993
The effects of KW-3635 (sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl) ethylidene]-6,11-dihydrodibenz-[b,e]oxepine-2… 
Highly Cited
1992
1988
1988
  • N. Aoki, A. Lefer
  • Methods and findings in experimental and clinical…
  • 1988
  • Corpus ID: 22268136
Splanchnic artery occlusion (SAO) followed by release of the occlusive clamps produces circulatory shock characterized by an… 
1986
1986
The new specific thromboxane receptor antagonist, BM-13505, was infused intravenously (1 mg/kg bolus and 1 mg/kg hr continuous…